AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
The 50 most promising Israeli startups - 2024
2
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
3
Moritz code: Inside the mind of the best VC investor ever
4
AI data platform WEKA achieves unicorn status with $140 million Series E at $1.6B valuation
5
The new Zionism
More news

Cancer

20 stories about Cancer
רון בנצור

Sustained Drug Release Company UroGen Submits New Drug Application to FDA

12.07.18|Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
חדר מיון בית חולים שיבא תל השומר

Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight

05.07.18|CTech
The deal was announced in March, but intended buyer InSight backed out
בורסה בורסת תל אביב 5

Cancer Treatment Company BioCanCell Raises $22.9 Million in Private Placement

02.07.18|CTech
The company announced the issuance of 5.9 million new shares in April
כנס יזמות 2018 תניה אטיאס

Startup Uses Business Intelligence Toolkit to Help Patients Improve Healthcare Choices

20.06.18|Anat Danieli
Israel-based Medint collects and analyzes information from medical websites, social platforms, blogs, and forums to help patients make informed decisions
נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering

17.06.18|Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
האוניברסיטה העברית

Grail Teams Up with Israeli Researchers on Early Stage Cancer Detection

12.06.18|Lilach Baumer
Founded in 2016, California-based Grail raised over $1.5 billion to date to develop a blood-based cancer test
פרופסור זליג אשחר

Scientist Quarrel Over Kite Pharma Sale Royalties to be Settled Out of Court

28.05.18|Zohar Shahar Levy
Israeli immunologist Zelig Eshhar, who holds the patent for Kite Pharma’s anti-cancer technology, has been sued by a former student for infringement of patent rights
תל אביב בורסה Tel Aviv Stock Exchange

Attempting to Delist, Cancer Treatment Company BioCanCell Issues New Shares

23.04.18|Dror Reich
The company diluted existing investors that opposed its plans to delist from the Tel Aviv Stock Exchange
ענת כהן-דייג מנכ"לית קומפיוג'ן

AstraZeneca Signs Deal with Cancer Immunotherapy Company Compugen

03.04.18|Lilach Baumer
The deal has the potential to be worth over $200 million for Nasdaq-listed Compugen
אבי ויידמן מנכ"ל nucleai

AI Cancer Detection Startup Nucleai Raises $5 Million

05.03.18|Amarelle Wenkert
Nucleai develops a software that uses artificial intelligence to diagnose abnormalities in tissue samples, helping detect cancerous cells and other diseases
Commonsense Robotics אורי אברהם אלרם גורן אייל גורן

CTech’s Daily Israeli Tech News Roundup

15.02.18|CTech
Warehouse robotics startup CommonSense Robotics raises $20 million. From eye-tracking to break-up monitoring, love tech can be the next big thing
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Cancer Screening Company Raises $8 Million

15.02.18|Lilach Baumer
Israel-based Smart Medical Systems manufactures an add-on device for colon screening, meant to increase detection of pre-cancerous tissue
default image

Pharma Company BioCanCell Raises $25 million, Plans to Go Public in the U.S.

23.01.18|Asaf Shalev
The company said it will use the funding for clinical trials of BC-819, a drug being designed to treat early stage bladder cancer
פרופסור זליג אשחר

Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall

16.01.18|Zohar Shahar Levy
Zelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights
פרופסור זליג אשחר

Immunologists Exchange Verbal Blows in Legal Fight Over Kite Pharma Windfall

26.12.17|Zohar Shahar Levy
In August, Gilead Science bought anti-cancer treatment company Kite Pharma for $11.9 billion. Two Israeli scientists involved in the early research that led to the company’s breakthrough are now quarreling over patent royalty payments
מייסד קייט פארמה אריה בלדגרין

Gilead Builds on Kite Pharma Acquisition, Buys Second CAR-T Therapy Company

10.12.17|Lilach Baumer
California-based Cell Design Labs will be acquired in a deal valued at up to $567 million
המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer
The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor
דרור חרץ מנכ"ל VBL

VBL Therapeutics Aims to Raise $18.75 Million in Public Offering

20.11.17|Lilach Baumer
The cancer treatment company announced an offering of 2.5 million shares last week
default image

Pontifax Leads $9.5 Funding Round for Biopharmaceutical Company ArQule

19.11.17|CTech
Nasdaq-listed ArQule develops treatments for cancer and rare diseases
default image

Generic Focus made Kite Pharma Founder Leave Teva

13.11.17|Dror Reich
Founder of cancer treatment company sold to Gilead Sciences for $12 billion, says Gilead wants “to crack the cancer market"
Previous ArticlesMore Articles